Causes of Acute Metabolic Encephalopathy
The primary causes of acute metabolic encephalopathy include electrolyte imbalances, hepatic dysfunction with elevated ammonia levels, infections, renal dysfunction, hypo/hyperglycemia, alcohol or drug toxicity, and thiamine deficiency. 1
Definition and Clinical Presentation
- Acute metabolic encephalopathy is characterized by altered level of consciousness, changes in affect, and possible focal neurological signs including speech disorders, seizures, and cranial nerve dysfunctions 1
- Clinical presentation can range from mild executive dysfunction to deep coma with decerebrate posturing 2
- Symptoms typically develop acutely and may fluctuate in severity 1
Major Causes
Hepatic Dysfunction
- Hepatic encephalopathy is a common form of metabolic encephalopathy caused by liver failure and elevated ammonia levels 3
- Alcohol-related liver disease can cause both direct neurotoxicity and hepatic encephalopathy, making it difficult to distinguish between these mechanisms 3
- Metabolic dysfunction-associated fatty liver disease (MAFLD) can impair neurocognitive function even in non-cirrhotic stages 3
- Porto-sinusoidal hypertension can cause encephalopathy due to large portosystemic shunts even without significant liver dysfunction 3
Electrolyte Disturbances
- Hyponatremia is a significant risk factor for encephalopathy, with a critical threshold of <130 mmol/L 3
- Hyponatremia causes cerebral edema with extracellular hypo-osmolality, which synergizes with other metabolic disturbances 3
- Other electrolyte imbalances including dyskalaemia (potassium abnormalities) can precipitate encephalopathy 3, 1
Renal Dysfunction
- Acute kidney injury and chronic kidney disease can cause metabolic encephalopathy through multiple mechanisms 3
- Renal dysfunction leads to protein catabolism, amino acid metabolism abnormalities, and peripheral insulin resistance 3
- Uremic encephalopathy results from accumulation of uremic toxins affecting brain function 3
Medications and Toxins
- Benzodiazepines and opioid analgesics are independently associated with increased risk of encephalopathy in susceptible patients 3
- Proton pump inhibitors (PPIs) can increase the risk of encephalopathy by promoting intestinal dysbiosis and bacterial translocation 3
- Toluene and other solvents can cause toxic leukoencephalopathy 4
Infections
- Systemic infections, particularly urinary tract infections and pneumonia, can precipitate metabolic encephalopathy 3
- Inflammatory markers and bacterial endotoxins can contribute to neuroinflammation and cerebral dysfunction 3
Glucose Abnormalities
- Both hypoglycemia and hyperglycemia can cause acute metabolic encephalopathy 1, 5
- Insulin resistance and abnormal glucose metabolism are common in patients with liver or kidney dysfunction 3
Inherited Metabolic Disorders
- Urea cycle disorders, amino acid metabolism disorders, organic acid metabolism disorders, and fatty acid metabolism disorders can cause acute metabolic encephalopathy 6
- Mitochondrial diseases and mutations in thiamine-transporter genes can lead to metabolic encephalopathy 6
Nutritional Deficiencies
- Thiamine deficiency is a significant cause of metabolic encephalopathy, particularly in alcoholics 3
- Malnutrition can exacerbate metabolic disturbances and contribute to encephalopathy 3
Diagnostic Approach
- Comprehensive evaluation should include blood tests for glucose, electrolytes, inflammatory markers, full blood count, blood alcohol level, and ammonia 3
- Thyroid function tests, brain imaging, screening for psychoactive drugs, and lumbar puncture may be necessary to rule out other causes 3
- Electroencephalogram (EEG) can help exclude non-convulsive seizures and assess severity of brain dysfunction 3, 1
Management Principles
- Identify and treat the underlying cause of metabolic encephalopathy 1, 5
- Correct electrolyte imbalances, particularly sodium disturbances 3, 1
- Avoid medications that can worsen encephalopathy, such as benzodiazepines and opioids in hepatic encephalopathy 3
- Monitor sodium levels in patients with decompensated cirrhosis to prevent hyponatremia-induced encephalopathy 3
- Limit PPI prescriptions to their strict validated indications in patients at risk 3
- Provide supportive care and symptomatic treatment as needed 1, 5
Clinical Pitfalls
- Alternative or additional causes of neuropsychiatric impairment should always be considered in patients with suspected metabolic encephalopathy 3
- Extrahepatic causes for acute encephalopathy are found in 22% of patients with liver disease initially suspected of hepatic encephalopathy 3
- During epidemics or pandemics, focus on infectious causes may lead to missed diagnoses of metabolic encephalopathies 1
- Patients with pre-existing neurological conditions may present atypically 1